IPHA Annual Meeting2010

ENTERPRISE AND HEALTHSOLUTIONS FOR IRISHPATIENTS AND THE IRISHECONOMY

Aviva Stadium, 25th November 2010

Supporting Irish patients and the Irish economy

Agenda

THE PHARMACEUTICAL SECTOR GENERATES 58PERCENT OF THE COUNTRY’S EXPORTS WHICHCONTRIBUTES TO MAKING IRELAND THE SECONDLARGEST NET EXPORTER OF MEDICINES IN THEWORLD.

THE PHARMACEUTICAL SECTOR DIRECTLY EMPLOYSOVER 24,500 PEOPLE, OVER HALF OF WHICH ARETHIRD LEVEL GRADUATES.

MEDICINES HAVE HELPED TO IMPROVE LIFE EXPECTANCY INIRELAND BY OVER A THIRD IN THE LAST SEVENTY YEARS, FROM57 IN 1925 TO 79 TODAY.

THE USE OF MEDICINES HAS CONTRIBUTED TO REDUCING THENUMBER OF DEATHS FROM HEART DISEASE AND STROKE BYNEARLY A HALF.

9.00 am Mr David Gallagher, President, IPHAWelcome address to the 17th IPHA Annual Meeting

9.10 am Mr Bryan Dobson, Anchor with RTÉ Six One NewsIntroduction and agenda summary

Session 1:Securing the future of the internationalresearch-based pharmaceutical industry inIreland

9.15 am Mr Barry O’Leary, Chief Executive, IDA IrelandThe IDA Ireland strategy for the pharmaceuticalindustry in Ireland

9.30 am Dr Ruth Barrington, Director, Molecular MedicineIrelandThe role of clinical research in securing the future ofthe industry in Ireland

9.45 am Mr Pat O’Mahony, Irish Medicines BoardThe contribution of a world-class regulatoryenvironment to the future of the industry in Ireland

Q&A

THE USE OF MEDICINES HASHELPED THOUSANDS OF IRISHPATIENTS WITH PARKINSON’S,ALZHEIMER’S, ULCERS, CANCER,DIABETES AND MENTAL ILLNESSTO LEAD BETTER AND MORENORMAL LIVES, EASING THEBURDEN ON CARE-GIVERS ANDDELAYING OR AVOIDING COSTLYLONG-TERM NURSING CARE.

MEDICINES HAVE HELPED TOENABLE IRISH HOSPITALS TOTREAT MORE PATIENTS ON A DAYCASE BASIS, FROM 85,000 CASESIN 1987 TO AN ESTIMATED770,000 IN 2008.

Session 2:Panel discussion – How to ensure the bestutilisation of healthcare resources(facilitated by Mr Bryan Dobson)

10.30 am Prof Frances Ruane, Chairperson of the ExpertGroup on Resource Allocation in the Health Sector,Executive Director of the ESRIThe economist perspective

Dr Fergus O'Ferrall, Adelaide Lecturer in HealthPolicy, Department of Public Health and PrimaryCare, Trinity College DublinThe universal health insurance advocate perspective

Mr Jimmy Tolan, Chief Executive, VHI The health insurance sector perspective

Q&A

11.30 am Coffee/tea break

Session 3Ensuring the best health outcomes for Irishpatients while securing value for money

12.00 pm Mr David Gallagher, President, IPHAThe value of medicines and vaccines to Irish patients

12.15 pm Dr Michael Barry, Clinical Director, National Centrefor PharmacoeconomicsThe role of Health Technology Assessment andcurrent developments in Ireland

12.30 pm Dr Barry White, National Director of Quality andClinical Care, Health Service ExecutiveThe development of national programmes of care,clinical pathways, therapeutic guidelines etc.

Q&A

1.00 pm Ms Anne Nolan, Chief Executive, IPHASummary and close

* Please note that all of the presentations and a podcast of theAnnual Meeting will be available on the IPHA website (www.ipha.ie)on Monday, 29th November 2010.

The Irish Pharmaceutical Healthcare Association (IPHA) represents the internationalresearch based pharmaceutical industry in Ireland. Our members include bothmanufacturers of prescription medicines and non-prescription or consumer healthcare medicines. Today people in Ireland live longer, healthier and more active lives,in part, due to medical progress and the use of new innovative medicines. Not only isthe pharmaceutical industry critical to the health of the nation, it plays a critical andsubstantial role in the Irish economy.

Irish Pharmaceutical Healthcare AssociationFranklin House140 Pembroke RoadDublin 4Ireland

Tel: (353 1) 660 3350Fax: (353 1) 668 6672E-mail: info@ipha.ie www.ipha.ie www.medicines.ie www.feelbetter.ie www.self-care.ie

Follow the IPHA on...